Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             112 results found
no title author magazine year volume issue page(s) type
1 E-Poster Viewing
108 S p.
article
2 Invited Speakers
108 S p.
article
3 Oral Presentations
108 S p.
article
4 Poster Pitch Presentations
108 S p.
article
5 Presentation name: Hereditary predisposition to MDS Godley, Lucy

108 S p.
article
6 Presentation name: High-Risk MDS Mayer, Margaret

108 S p.
article
7 Presentation Name: How machine learning can contribute to prognostic and predictive models Nazha, Aziz

108 S p.
article
8 Presentation name: Immunotherapy strategies in MDS (vaccines, CAR-T) Gill, Saar

108 S p.
article
9 Presentation name: Inflammatory signaling in the pathogenesis of MDS Sallman, David A.

108 S p.
article
10 Presentation Name: Insights from the MDS transcriptome Boultwood, Jacqueline

108 S p.
article
11 Presentation name: Management of low-risk disease- now and future Platzbecker, Uwe

108 S p.
article
12 Presentation name: MDS progression to AML Murray, Cindy

108 S p.
article
13 Presentation name: Mechanisms and predictors of drug resistance, intolerance to HMAs and clinical management strategies in high-risk MDS Sekeres, Mikkael

108 S p.
article
14 Presentation name: Strategies to reduce relapse and improve survival post allogeneic stem cell transplant Cutler, Corey

108 S p.
article
15 Presentation name: Supportive Care Tinsley-Vance, Sara

108 S p.
article
16 Presentation name: TGFbeta pathway targeting Verma, Amit

108 S p.
article
17 Presentation name: What should be the clinical targets of iron chelation therapy Leitch, Heather

108 S p.
article
18 Presentation name: What we learn from real-world registries de Witte, Prof. Dr. Theo

108 S p.
article
19 The Tito Bastianello Awards
108 S p.
article
20 Topic: AS01-Diagnosis/AS01a-Cytomorphology Ma, J.

108 S p.
article
21 Topic: AS01-Diagnosis/AS01b-Flow cytometry Vicenzetto, C.

108 S p.
article
22 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Garcia, Y. Oliveira

108 S p.
article
23 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Chai, J.

108 S p.
article
24 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Todisco, G.

108 S p.
article
25 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Ferrone, C.K.

108 S p.
article
26 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Eder, L.N.

108 S p.
article
27 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Ferrone, C.K.

108 S p.
article
28 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Huang, H.

108 S p.
article
29 Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression) Træden, D.

108 S p.
article
30 Topic: AS02-Epidemiology Brailovski, E.

108 S p.
article
31 Topic: AS02-Epidemiology Dinmohamed, A.

108 S p.
article
32 Topic: AS02-Epidemiology Kuendgen, A.

108 S p.
article
33 Topic: AS02-Epidemiology Al Sabty, I.

108 S p.
article
34 Topic: AS02-Epidemiology Jonasova, A.

108 S p.
article
35 Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care Kota, V.

108 S p.
article
36 Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care Zeidan, A.M.

108 S p.
article
37 Topic: AS03-Health Economics & Outcome Research/AS03b-Patient-reported outcomes Bradford, A.

108 S p.
article
38 Topic: AS03-Health Economics & Outcome Research/AS03b-Patient-reported outcomes Haring, Y.

108 S p.
article
39 Topic: AS03-Health Economics & Outcome Research/AS03b-Patient-reported outcomes Dubow, J.

108 S p.
article
40 Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells Saiki, R.

108 S p.
article
41 Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells Yeung, T.

108 S p.
article
42 Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution Sahoo, S.

108 S p.
article
43 Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution Makishima, H.

108 S p.
article
44 Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution Cross, J.

108 S p.
article
45 Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution Hartmann, L.

108 S p.
article
46 Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution Mohedo, F. Hernández

108 S p.
article
47 Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX) Fernandez-Orth, J.

108 S p.
article
48 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Huang, H.

108 S p.
article
49 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Xu, F.

108 S p.
article
50 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Zemanova, Z.

108 S p.
article
51 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Gurnari, C.

108 S p.
article
52 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Adema, V.

108 S p.
article
53 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Polprasert, C.

108 S p.
article
54 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Pu, J.

108 S p.
article
55 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Zavras, P.

108 S p.
article
56 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Chiusolo, P.

108 S p.
article
57 Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations Huang, H.

108 S p.
article
58 Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling Kaisrlikova, M.

108 S p.
article
59 Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling Rai, R.

108 S p.
article
60 Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling Merkerova, M.

108 S p.
article
61 Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling Sousa, T.E.

108 S p.
article
62 Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling Gurnari, C.

108 S p.
article
63 Topic: AS04-MDS Biology and Pathogenesis/AS04g-Epigenetic deregulation Poulaki, A.

108 S p.
article
64 Topic: AS04-MDS Biology and Pathogenesis/AS04g-Epigenetic deregulation Brogi, A.

108 S p.
article
65 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Molero, A.

108 S p.
article
66 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Molero, A.

108 S p.
article
67 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Van Ens, D.

108 S p.
article
68 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Feld, J.

108 S p.
article
69 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Pagliuca, S.

108 S p.
article
70 Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation Calabretto, G.

108 S p.
article
71 Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche Wobus, M.

108 S p.
article
72 Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche Malka, R.

108 S p.
article
73 Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche Solas, T. Jiménez

108 S p.
article
74 Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche Kutyna, M.

108 S p.
article
75 Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche Jann, J.-C.

108 S p.
article
76 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Izquierdo, M. Martín

108 S p.
article
77 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Lovatel, V.

108 S p.
article
78 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Cedena, M.T.

108 S p.
article
79 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Poza, M.

108 S p.
article
80 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Blazevic, D.

108 S p.
article
81 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Bär, T.

108 S p.
article
82 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Smoljanovic, I. Mandac

108 S p.
article
83 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Silzle, T.

108 S p.
article
84 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Hiwase, D.

108 S p.
article
85 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Arenillas, L.

108 S p.
article
86 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Roman, D.

108 S p.
article
87 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Efraim, M.

108 S p.
article
88 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Rabinowitz, R. Book

108 S p.
article
89 Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment Trubkina, H.

108 S p.
article
90 Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment Kubasch, A.S.

108 S p.
article
91 Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment Yoshimi, A.

108 S p.
article
92 Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment Cheng, J.

108 S p.
article
93 Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes Bortnick, R.

108 S p.
article
94 Topic: AS08-Treatment/AS08a-Current treatment options - Hypomethylating agents Savona, M.

108 S p.
article
95 Topic: AS08-Treatment/AS08a-Current treatment options - Hypomethylating agents Šimoničová, K.

108 S p.
article
96 Topic: AS08-Treatment/AS08a-Current treatment options - Hypomethylating agents Neokleous, N.

108 S p.
article
97 Topic: AS08-Treatment/AS08b-Current treatment options -Lenalidomide Kravetz, E.

108 S p.
article
98 Topic: AS08-Treatment/AS08e-New developments - Preclinical studies Gharaee, N.

108 S p.
article
99 Topic: AS08-Treatment/AS08e-New developments - Preclinical studies Schmitt, N.

108 S p.
article
100 Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III Cluzeau, T.

108 S p.
article
101 Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III Peterlin, P.

108 S p.
article
102 Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III Zeidan, A.M.

108 S p.
article
103 Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation - Bridging to transplantation Crisà, E.

108 S p.
article
104 Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation Song, Z.

108 S p.
article
105 Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation Garnier, A.

108 S p.
article
106 Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation Duarte, F.

108 S p.
article
107 Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation - Bridging to transplantation Khattab, E.

108 S p.
article
108 Topic: AS08-Treatment/AS08i-Allogeneic hematopoietic cell transplantation -Post-transplantation treatment Choi, E.-J.

108 S p.
article
109 Topic: AS08-Treatment/AS08j-Supportive care - Iron overload Leitch, H.

108 S p.
article
110 Topic: AS08-Treatment/AS08j-Supportive care - Iron overload Zhang, Y.

108 S p.
article
111 Topic: AS08-Treatment/AS08j-Supportive care - Iron overload Rozema, J.

108 S p.
article
112 Topic: AS08-Treatment/AS08k-Supportive care - Transfusion medicine and MDS Mahillo, B. Astibia

108 S p.
article
                             112 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands